SCHEMBL7716569

SCHEMBL7716569

C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)/C=C/[C@H](O)C3(C(=O)CCC)CC3)CC[C@@H]12

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.68
▸ ALOX15 P16050 3/20 0.68
▸ CYP3A4 P08684 3/20 0.68
▸ LMNA P02545 2/20 0.68
▸ HSPD1 P10809 2/20 0.68
▸ PTGS1 P23219 2/20 0.68
▸ HSPE1 P61604 2/20 0.68
▸ ADRA1A P35348 2/20 0.68
▸ AR P10275 1/20 0.68
▸ TSHR P16473 1/20 0.68
▸ CYP2C9 P11712 1/20 0.68
▸ CYP2C19 P33261 1/20 0.68
▸ USP2 O75604 1/20 0.68
▸ ABCB11 O95342 1/20 0.68
▸ ESR1 P03372 1/20 0.68
▸ TST Q16762 1/20 0.68
▸ VDR P11473 6/20 0.64
▸ MEN1 O00255 3/20 0.58
▸ KMT2A Q03164 3/20 0.58
▸ MAPT P10636 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7710871 1.00 ALDH1A1 (0.68) ALDH1A1ALOX15CYP3A4LMNAHSPD1
SCHEMBL7710878 0.95 VDR (0.67) ALDH1A1ALOX15CYP3A4LMNAHSPD1
SCHEMBL7716712 0.95 VDR (0.67) ALDH1A1ALOX15CYP3A4LMNAHSPD1
SCHEMBL7715065 0.95 VDR (0.66) ALDH1A1ALOX15CYP3A4LMNAHSPD1
SCHEMBL7718611 0.95 VDR (0.66) ALDH1A1ALOX15CYP3A4LMNAHSPD1
SCHEMBL8188404 0.94 VDR (0.65) ALDH1A1ALOX15CYP3A4LMNAHSPD1
SCHEMBL7715741 0.94 VDR (0.65) ALDH1A1ALOX15CYP3A4LMNAHSPD1
SCHEMBL8179553 0.94 VDR (0.65) ALDH1A1ALOX15CYP3A4LMNAHSPD1
SCHEMBL8189720 0.94 VDR (0.65) ALDH1A1ALOX15CYP3A4LMNAHSPD1
SCHEMBL7715719 0.94 VDR (0.65) ALDH1A1ALOX15CYP3A4LMNAHSPD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6372731-B1 TREATMENT OF CELL PROLIFERATION AND BONE DISORDERS SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-16 — — US claimed
EP-0832063-B1 VITAMIN D DERIVATIVES WITH C-25 SUBSTITUENTS, PROCESS FOR THEIR PREPARATION, INTERMEDIATE PRODUCTS AND THEIR USE IN PREPARING MEDICAMENTS SCHERING AG (DE) 2000-02-23 — — EP claimed
US-6376480-B1 TREATMENT OF IMMUNE SYSTEM DISORDERS, OSTEOPOROSIS, ALOPECIA SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-23 — — US disclosed
US-6372731-B1 TREATMENT OF CELL PROLIFERATION AND BONE DISORDERS SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-16 — — US disclosed
EP-0832063-B1 VITAMIN D DERIVATIVES WITH C-25 SUBSTITUENTS, PROCESS FOR THEIR PREPARATION, INTERMEDIATE PRODUCTS AND THEIR USE IN PREPARING MEDICAMENTS SCHERING AG (DE) 2000-02-23 — — EP disclosed
Send feedback